Publication | Closed Access

VANUTIDE CRIDIFICAR (ACC-001) AND QS-21 ADJUVANT IN INDIVIDUALS WITH EARLY ALZHEIMER’S DISEASE: AMYLOID IMAGING POSITRON EMISSION TOMOGRAPHY AND SAFETY RESULTS FROM A PHASE 2 STUDY

Neurodegenerative DiseasesAlzheimer's DiseaseVanutide CridificarNeurochemical BiomarkersNeurologyAging-associated DiseaseMedicineGeriatric Neurology